Dandelion for Anti-Inflammatory

Research suggests that dandelion possesses measurable anti-inflammatory properties, with multiple preclinical studies demonstrating reductions in key inflammatory markers such as TNF-α, IL-6, IL-1β, nitric oxide, and NF-κB across a range of laboratory models. Studies indicate that several of dandelion's bioactive compounds — including taraxasterol, cichoric acid, luteolin, chlorogenic acid, and various polysaccharides — appear to drive these effects through multiple biological pathways, and two reviews of the broader literature characterize dandelion as a chemically complex plant with consistently documented anti-inflammatory activity in cell and animal research. The available evidence consists entirely of in vitro studies, animal experiments, and narrative reviews, with no human clinical trials identified, which represents a significant limitation in assessing whether these findings would translate to people. Overall, the research direction is generally supportive but remains preliminary, and the absence of controlled human studies means no firm conclusions can be drawn about the effectiveness of dandelion as an anti-inflammatory agent in clinical settings.